Summary of Study ST002182
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001389. The data can be accessed directly via it's Project DOI: 10.21228/M85T47 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Study ID | ST002182 |
Study Title | Amelioration of developmental programming of NAFLD in weanling liver using PQQ |
Study Type | Diet and PQQ treatment |
Study Summary | Maternal obesity and consumption of a high-fat diet significantly elevate risk for pediatric non-alcoholic fatty liver disease (NAFLD), affecting 10% of children in the US. Almost half of these children are diagnosed with nonalcoholic steatohepatitis (NASH), a leading etiology for liver transplant. Animal models show that signs of liver injury and perturbed lipid metabolism asso-ciated with NAFLD begin in utero; however, safe dietary therapeutics to blunt developmental programming of NAFLD are unavailable. Using a mouse model of maternal Western-style diet (WD), we previously showed that pyrroloquinoline quinone (PQQ), a potent dietary antioxidant, protected offspring of WD-fed dams from development of NAFLD and NASH. Here, we used untargeted mass spectrometry-based lipidomics to delineate lipotoxic effects of WD on offspring liver and identify lipid targets of PQQ. PQQ exposure during pregnancy altered hepatic lipid profiles of WD-exposed offspring, upregulating peroxisome proliferator-activated receptor (PPAR) α signaling and mitochondrial fatty acid oxidation to markedly attenuate triglyceride accumulation beginning in utero. Surprisingly, the abundance of very long-chain ceramides, important in promoting gut barrier and hepatic function, was significantly elevated in PQQ-treated offspring. PQQ exposure reduced the hepatic phosphatidylcho-line/phosphatidylethanolamine (PC/PE) ratio in WD-fed offspring and improved glucose toler-ance. Notably, levels of protective n − 3 polyunsaturated fatty acids (PUFAs) were elevated in offspring exposed to PQQ, beginning in utero, and the increase in n − 3 PUFAs persisted into adulthood. Our findings suggest that PQQ supplementation during gestation and lactation augments pathways involved in the biosynthesis of long-chain fatty acids and plays a unique role in modifying specific bioactive lipid species critical for protection against NAFLD risk in later life. |
Institute | University of Oklahoma Health Sciences Center |
Department | Biochemistry and Molecular Biology, Harold Hamm Diabetes Center |
Laboratory | Jonscher |
Last Name | Jonscher |
First Name | Karen |
Address | 975 NE 10th Street BRC-N 362A, Oklahoma City, OK, 73104, USA |
karen-jonscher@ouhsc.edu | |
Phone | 3032294620 |
Submit Date | 2022-04-20 |
Num Groups | 3 |
Total Subjects | 9 |
Publications | Jonscher, et al FASEB J 2017; Friedman, et al Hepatol Commun 2018 |
Analysis Type Detail | LC-MS |
Release Date | 2023-04-20 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Factors:
Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)
mb_sample_id | local_sample_id | Diet |
---|---|---|
SA209683 | 639.4 | CH |
SA209684 | 639.1 | CH |
SA209685 | 639.2 | CH |
SA209686 | 526.3 | WD |
SA209687 | 526.1 | WD |
SA209688 | 399.5 | WD |
SA209689 | 183.4 | WDPQQ |
SA209690 | 183.1 | WDPQQ |
SA209691 | 514.1 | WDPQQ |
Showing results 1 to 9 of 9 |